$ORKA SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Regulation FD Disclosure; Other Events ©2026 Oruka Therapeutics ©2026 ORUKA THERAPEUTICS EVERLAST - B Interim Data ORKA - 001 Phase 2b trial in psoriasis October 26, 2026
20 Oct 2026	Form 4: Quinlan Paul T, General Counsel Received 9,000 shares by exercise or conversion ($70.2K) · Sold 9,000 shares ($707K)
15 Oct 2026	Form 4: Goncalves Joana, Chief Medical Officer Received 7,000 shares by exercise or conversion ($51.2K) · Sold 7,000 shares ($524K)
15 Oct 2026	144
13 Oct 2026	Form 4: Agarwal Arjun, Senior Vice President, Finance Received 9,999 shares by exercise or conversion ($157K) · Sold 9,999 shares ($806K)
13 Oct 2026	144
02 Oct 2026	Form 4: Klein Lawrence Otto, Director Received 25,000 shares by exercise or conversion ($195K) · Sold 25,000 shares ($2.09M)
01 Oct 2026	144
21 Sep 2026	Form 4: Agarwal Arjun, Senior Vice President, Finance Sold 533 shares ($51K)
21 Sep 2026	Form 4: Quinlan Paul T, General Counsel Received 10,000 shares by exercise or conversion ($78K) · Sold 10,000 shares ($936K)
21 Sep 2026	144
15 Sep 2026	Form 4: Goncalves Joana, Chief Medical Officer Received 7,000 shares by exercise or conversion ($51.2K) · Sold 7,947 shares ($734K)
15 Sep 2026	Form 4: Agarwal Arjun, Senior Vice President, Finance Received 9,459 shares by exercise or conversion ($150K) · Sold 9,459 shares ($872K) · Sold 560 shares ($53.6K)
15 Sep 2026	Form 4: Klein Lawrence Otto, Director Sold 2,452 shares ($235K)
15 Sep 2026	Form 4: Quinlan Paul T, General Counsel Sold 1,039 shares ($99.4K)
15 Sep 2026	Form 4: Sandler Laura Lee, Chief Operating Officer Sold 906 shares ($86.7K)
01 Sep 2026	Form 4: Sandler Laura Lee, Chief Operating Officer Received 5,000 shares by exercise or conversion ($39K) · Sold 5,000 shares ($459K)
01 Sep 2026	Form 4: Klein Lawrence Otto, Director Received 75,000 shares by exercise or conversion ($585K) · Sold 75,000 shares ($6.89M)
01 Sep 2026	144
01 Sep 2026	144

Comments